In children with nephrotic syndrome, can fresh frozen plasma be used as an alternative to albumin, together with furosemide, for edema control?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Fresh Frozen Plasma Should NOT Be Used as an Alternative to Albumin for Edema Control in Nephrotic Syndrome

Fresh frozen plasma (FFP) is not recommended and should not be used as an alternative to albumin for edema management in children with nephrotic syndrome. There is no evidence supporting FFP use for this indication, and it carries unnecessary risks including volume overload, transfusion reactions, and infectious complications.

Evidence-Based Approach to Edema Management

First-Line Treatment: Loop Diuretics Alone

The KDIGO 2021 guideline establishes loop diuretics as first-line therapy for edema in nephrotic syndrome 1. Furosemide is FDA-approved for treating edema associated with nephrotic syndrome in both adults and children 2.

Key diuretic strategies 1:

  • Start with furosemide as monotherapy
  • Use twice-daily dosing (preferred over once daily)
  • Escalate dose until clinically significant diuresis occurs or maximum effective dose reached
  • Consider switching to longer-acting loop diuretics (bumetanide or torsemide) if furosemide fails

Volume Status Assessment is Critical

Before considering albumin, determine if the patient has volume contraction versus volume expansion 3:

Volume contraction indicators:

  • Fractional excretion of sodium (FeNa) <0.2%
  • Higher BUN and BUN/creatinine ratio
  • Higher urine osmolality
  • Lower urine sodium
  • Elevated renin, aldosterone, and ADH levels

Volume expansion patients (FeNa ≥0.2%):

  • Treat with diuretics alone (IV furosemide + oral spironolactone)
  • Do NOT give albumin—this can precipitate dangerous fluid overload 3

When to Consider Albumin (Not FFP)

Albumin plus furosemide may be considered only in select cases of volume-contracted patients with severe, refractory edema 1, 4. However, the evidence is extremely limited:

  • Only one small RCT (26 children) showed transient benefit with albumin plus furosemide versus dextrose 5
  • A 2022 systematic review found albumin increased urine output short-term but with inconclusive sodium excretion results 6
  • A 2025 systematic review concluded evidence is "extremely limited" and routine use is not justified 7
  • Effects are transient and patient-centered outcomes remain unassessed 7

The KDIGO guideline lists albumin with loop diuretics only as a strategy for diuretic-resistant patients, not as routine therapy 1.

Diuretic-Resistant Edema Algorithm

For patients not responding to loop diuretics alone 1:

  1. Add mechanistically different diuretics for synergy:

    • Thiazide-like diuretics (any high-dose thiazide equally effective)
    • Spironolactone (also counters hypokalemia, helps metabolic alkalosis)
    • Amiloride (counters hypokalemia, improves metabolic alkalosis)
    • Acetazolamide (may help but weak diuretic)

  2. Only after optimizing diuretic combinations, consider:

    • Loop diuretics with IV albumin (in volume-contracted patients only)
    • Ultrafiltration or hemodialysis for severe cases

Critical Safety Considerations

Furosemide monitoring requirements 2:

  • Check electrolytes (hypokalemia, hyponatremia risk)
  • Monitor renal function (avoid volume depletion)
  • In premature infants: risk of nephrocalcinosis/nephrolithiasis—perform renal ultrasound
  • Avoid in combination with aminoglycosides (ototoxicity risk)
  • Use cautiously with ACE inhibitors/ARBs (severe hypotension, renal failure risk)

Sodium restriction is essential: Limit to <2.0 g/day (<90 mmol/day) 1

Why FFP is Inappropriate

Fresh frozen plasma:

  • Contains clotting factors, not primarily albumin
  • Provides inadequate albumin concentration for oncotic effect
  • Carries transfusion risks (allergic reactions, TRALI, infections)
  • Has no evidence base for nephrotic edema
  • Is not mentioned in any guideline for this indication

If albumin is deemed necessary after proper volume assessment and diuretic optimization, use pharmaceutical-grade human albumin (20% or 25%), not FFP.

Common Pitfalls to Avoid

  • Do not routinely give albumin without assessing volume status—you may worsen outcomes in volume-expanded patients 3
  • Do not use FFP as an albumin substitute—it is ineffective and dangerous for this indication
  • Do not start ACE inhibitors/ARBs during acute nephrotic syndrome presentation—risk of acute kidney injury, especially in minimal change disease 1
  • Do not underdose loop diuretics—escalate to effective doses before adding other agents
  • Do not forget sodium restriction—diuretics alone will fail without dietary compliance

Human albumin has very limited evidence even when properly indicated; FFP has none and should never be used for nephrotic edema management.

References

3
Research

Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study.

Clinical journal of the American Society of Nephrology : CJASN, 2009

5
Research

Human albumin infusion for treating oedema in people with nephrotic syndrome.

The Cochrane database of systematic reviews, 2019

Related Questions

In a child with nephrotic syndrome and edema, how should I manage the condition if albumin is not available?
In a child with nephrotic‑range proteinuria and severe hypoalbuminemia who has a blood pressure of 90/60 mm Hg, should albumin infusion be administered?
Is there evidence for using albumin with furosemide (Lasix) to enhance diuresis in patients with nephrotic syndrome and significant edema?
Is intravenous (IV) albumin therapy effective for treating nephrotic syndrome?
What's the next step in managing severe edema in a patient with bilateral Deep Vein Thrombosis (DVT) on Xarelto (rivaroxaban) 15 mg twice daily, who has failed initial diuretic therapy?
In a newborn with perioral cyanosis and a systolic blood pressure gradient between the upper and lower extremities, what is the best next step in management?
In a patient who underwent chemotherapy for lung cancer ten years ago and now presents with fever, night sweats, weight loss (B symptoms) and leukocytosis, what is the appropriate diagnostic workup and differential diagnosis?
In an 11-year-old female with nocturnal enuresis and microscopic hematuria (3–5 red blood cells per high-power field) on urinalysis, what further workup is indicated?
What second‑generation antihistamine is recommended for an elderly patient, and how should dosing be adjusted for renal impairment?
In a 10‑day‑old infant with absent femoral pulses, what is the first‑line management?
What is an uncomplicated urinary tract infection (UTI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.